Polycystic ovary syndrome is an endocrine disorder characterized by insulin resistance, hyperandrogenemia, obesity, and inflammation, and is the most common cause of infertility. Women with PCOS are at higher risk than non-PCOS women for diabetes, cardiovascular disease, endometrial cancer, and psychiatric disorders. Because many abnormalities present in PCOS and symptoms vary considerably among PCOS women, treatment is guided by presentation and does not consist of simply one modality. Often, however, one type of medication can ameliorate more than one abnormality in PCOS. This review summarizes current research on several treatment modalities for PCOS, including drugs that are fairly well-established as efficacious and other agents that may prove efficacious in the future, with particular emphasis on the benefits and barriers of lifestyle change.
CITATION STYLE
Farrell-Turner, K. A. (2011). Polycystic Ovary Syndrome: Update on Treatment Options and Treatment Considerations for the Future. Clinical Medicine Insights: Women’s Health, 4, CMWH.S6715. https://doi.org/10.4137/cmwh.s6715
Mendeley helps you to discover research relevant for your work.